Sutro, Pfizer sign multi-year protein drug deal
In its first licensing agreement, protein drug developer Sutro Biopharma Inc. has teamed up with Pfizer Inc. in the research, development and commercialization of peptide therapeutics.
- Large Molecule
- Synthesis Technologies, Production Processes
- Includes Royalty or Profit Split Information
- R&D and Marketing (Licensing)
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.